Product Information
GUANFACINE 1 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1466 per EA under NDC 29300045801. Its NADAC has been published 273 times since Apr 28, 2021.
FDA first approved this application on Mar 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300045801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUANFACINEApproval Type
Generic (ANDA)
FDA Application
ANDA214689FDA Approved
3/3/2021
TE Code
AB
On Market Since
3/3/2021
Pharmacological Classes
Price Statistics
The NADAC for GUANFACINE 1 MG TABLET has been published 273 times since Apr 28, 2021, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1466 per EA |
|---|---|
| All-time high | $0.5048 (Apr 13, 2022) |
| All-time low | $0.1400 (Mar 18, 2026) |
| 52-week high | $0.1690 |
| 52-week low | $0.1400 |
| Median price | $0.3114 |
| Average price | $0.3010 |
| Largest weekly change | +66.5% (Aug 21, 2024) |
| Weeks tracked | 273 |
| Tracking since | Apr 28, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guanfacine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUANFACINE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUANFACINE 1 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1466 per EA (NDC 29300045801), effective Sep 30, 2026.
How has the price of GUANFACINE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUANFACINE 1 MG TABLET has declined 52.9%. It has been tracked across 273 weekly CMS publications since Apr 28, 2021.
What are the highest and lowest recorded NADAC prices for GUANFACINE 1 MG TABLET?
Since Apr 28, 2021, the NADAC for GUANFACINE 1 MG TABLET has ranged from a low of $0.1400 (Mar 18, 2026) to a high of $0.5048 (Apr 13, 2022), with a median of $0.3114 per EA.
Are there cheaper alternatives to GUANFACINE 1 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GUANFACINE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GUANFACINE 1 MG TABLET?
GUANFACINE 1 MG TABLET (NDC 29300045801) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.